Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

Non-Interventional, Multi-center Registry of Recording of Treatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

• To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece

• To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece
• To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival
• To record adverse events per line of therapy
• To recording of the causes of treatment discontinuation per line of therapy

Inclusion Criteria:

• Women with histological confirmed ER/PR positive, HER2-negative MBC
• Age >18 years old
• Patients initiating first or second line therapy for ER/PR positive, HER2-negative MBC
• Adequate hematologic, renal and hepatic function
• Signed informed consent (ICF)

Exclusion Criteria:

• Active malignancy other than MBC
• Active infection